Caidya
康缔亚
elsewhere's corpus covers Caidya (康缔亚) only thinly. What can be said from the material: it is a Qiming Venture Partners portfolio company, repeatedly named by Qiming among its investments "that have grown into some of the most influential companies in their fields," alongside names like Sino Biological (神州细胞) and WeRide . Beyond that — what Caidya does, when it was founded, its size or funding — elsewhere's corpus does not cover, so no fuller profile can be given here.
AI-generated — may contain errors, please verify.
Coverage
Morning Star | Five Qiming Venture Partners Portfolio Companies Named to BEYOND Awards MedTech Transcendence and Health Leadership Lists
The BEYOND Awards Medical Technology Transcendence List seeks to identify and honor the transcendent forces in medical technology that demonstrate exceptional innovation capabilities and achieve "defining industry top standards"; the Great Health Navigation List focuses on leading enterprises that truly meet consumer health needs and exhibit strong growth potential and outstanding innovation capabilities.
Qiming Venture Partners-backed Sinogen Pharma advises Genrix Bio on over $700M BCMA/CD3 out-license deal with Cullinan
SinoKin Pharmaceutical served as the business development advisor to Zhixiang Jintai, providing end-to-end commercial services that included evaluating different partnership models with several foreign biopharmaceutical companies and investment institutions, helping Zhixiang Jintai secure multiple investment agreements.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 19, 2025
Join us in celebrating milestone moments from Qiming Venture Partners' portfolio companies
Qiming ESG | Qiming Venture Partners Rural Revitalization Entrepreneur Support Program Holds 2025 Industry Entrepreneur Quality Development Exchange in Chengdu
The "Rural Revitalization Entrepreneurship Support Program" was jointly launched by Qiming Venture Partners and the China Foundation for Rural Development. It aims to leverage the respective resource advantages of both organizations in venture capital and philanthropy to provide sustained support for rural entrepreneurs.
Qiming Weekly | Qiming Venture Partners Portfolio Companies: Funding and Updates Vol. 18, 2025
Staying with you through milestone moments for Qiming Venture Partners' portfolio companies
Qiming Venture Partners' Duane Kuang: China's new quality productive forces are going global, and the venture capital industry can play an important role
Venture capital firms' tolerance for high risk and focus on long-term value inherently make them adventurous, willing to back technological innovation. By building a closed innovation loop that moves from "blood transfusion" to "blood creation," they can deeply embed themselves in company growth. And they have the ability to identify the most promising entrepreneurs and the most compelling directions for innovation.
Morning Star | Four Qiming Venture Partners Portfolio Companies Selected for S&P Global Sustainability Yearbook (China Edition) 2025
The Yearbook aims to identify and recognize Chinese companies that have demonstrated sustainable development advantages in industries such as biotechnology, healthcare, machinery and electrical equipment, automotive manufacturing, and communications equipment.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 17, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 16, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming View | Duane Kuang: The Time Is Ripe for Chinese Tech to Go Global
China's technology going global — the time is now. In the coming years, all kinds of our AI-related technologies will join this wave of going global as well. The trend of Chinese technology expanding worldwide is only just beginning.
Morning Star | Over 20 Qiming Venture Partners Portfolio Companies Named to 2025 China Future Unicorn Top 100 and Other Lists
The selection process isn't just a deep dive into innovative companies — it also gives investors a chance to spot potential winners.
Qiming Venture Partners and Portfolio Companies Win Multiple ChinaVenture Awards, Including Top 5 China VC Firm of 2024
The "ChinaVenture Rankings" have been published for 19 consecutive years, recognized within the industry for their professionalism, authority, and rigor. They are widely regarded as a bellwether for China's equity investment sector and serve as a key reference for capital commitments from many large institutional LPs.
Qiming Weekly | Qiming Venture Partners Portfolio Funding and Updates Roundup Vol. 13, 2025
Following Qiming Venture Partners' portfolio companies' milestone moments with you
Qiming Venture Partners Issues Stern Statement on Fraudulent Investment Scheme
Qiming Venture Partners-Backed Belief BioMed Announces Approval of China's First Hemophilia B Gene Therapy Drug Xinjining®
As China's first independently developed gene therapy for hemophilia B, Xinjiuning® will offer patients a completely new treatment option, with the potential to free them from a lifetime of frequent intravenous injections and help them return to a life without constraints.
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 11, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners and Four Portfolio Companies Named to PharmCube TOP15 Annual Awards
The awards aim to establish benchmark investment institutions and enterprises with annual bellwether significance for China's pharmaceutical industry.
Qiming Star | WeRide's Han Xu: The Ultimate Winner Will Prevail on Service Quality | Bilingual
WeRide is an international company dedicated to bringing autonomous driving services to the global market. The company is building a robust business development team and sales network, while developing a universal autonomous driving technology platform to support operations and services worldwide.
Qiming Weekly | Qiming Venture Partners Portfolio Funding and Updates Vol. 07, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
